{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,28]],"date-time":"2026-10-28T06:49:14Z","timestamp":1793170154372,"version":"4.5.0"},"reference-count":34,"publisher":"Springer Science and Business Media LLC","issue":"21-22","license":[{"start":{"date-parts":[[2010,12,1]],"date-time":"2010-12-01T00:00:00Z","timestamp":1291161600000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Wien Med Wochenschr"],"published-print":{"date-parts":[[2010,12]]},"DOI":"10.1007\/s10354-010-0845-7","type":"journal-article","created":{"date-parts":[[2010,12,17]],"date-time":"2010-12-17T07:53:35Z","timestamp":1292572415000},"page":"547-556","source":"Crossref","is-referenced-by-count":54,"title":["Efficacy and safety of silexan, a new, orally administered lavender oil preparation, in subthreshold anxiety disorder \u2013 evidence from clinical trials","Wirksamkeit und Vertr\u00e4glichkeit von Silexan, einer neuen, oral verabreichten Zubereitung aus Lavendel\u00f6l, bei subsyndromaler Angstst\u00f6rung \u2013 Evidenz aus klinischen Pr\u00fcfungen"],"prefix":"10.1007","volume":"160","author":[{"given":"Siegfried","family":"Kasper","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Markus","family":"Gastpar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Walter E.","family":"M\u00fcller","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hans-Peter","family":"Volz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hans-J\u00fcrgen","family":"M\u00f6ller","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Angelika","family":"Dienel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sandra","family":"Schl\u00e4fke","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","reference":[{"key":"845_CR1","unstructured":"American Psychiatric Association. Diagnostic and statistical manual of mental disorders: DSM-IV. American Psychiatric Association, Washington, DC, 1994"},{"key":"845_CR2","doi-asserted-by":"crossref","first-page":"78","DOI":"10.1002\/da.1020","volume":"13","author":"RM Carter","year":"2001","unstructured":"Carter RM, Wittchen HU, Pfister H, et al. One-year prevalence of subthreshold and threshold DSM-IV generalized anxiety disorder in a nationally representative sample. Depress Anxiety, 13: 78\u201388, 2001","journal-title":"Depress Anxiety"},{"key":"845_CR3","doi-asserted-by":"crossref","first-page":"1719","DOI":"10.1176\/ps.2006.57.12.1719","volume":"57","author":"CI Cohen","year":"2006","unstructured":"Cohen CI, Magai C, Yaffee R, et al. The prevalence of anxiety and associated factors in a multiracial sample of older adults. Psychiatr Serv, 57: 1719\u20131725, 2006","journal-title":"Psychiatr Serv"},{"key":"845_CR4","doi-asserted-by":"crossref","first-page":"173","DOI":"10.1016\/S0924-9338(00)00228-5","volume":"15","author":"R Heun","year":"2000","unstructured":"Heun R, Papassotiropoulos A, Ptok U. Subthreshold depressive and anxiety disorders in the elderly. Eur Psychiatry, 15: 173\u2013182, 2000","journal-title":"Eur Psychiatry"},{"issue":"Suppl 8","key":"845_CR5","first-page":"24","volume":"63","author":"HU Wittchen","year":"2002","unstructured":"Wittchen HU, Kessler RC, Beesdo K, et al. Generalized anxiety and depression in primary care: prevalence, recognition, and management. J Clin Psychiatry, 63(Suppl 8): 24\u201334, 2002","journal-title":"J Clin Psychiatry"},{"issue":"Pre-Publishing","key":"845_CR6","first-page":"1","volume":"10","author":"HP Volz","year":"2009","unstructured":"Volz HP, Gastpar M, Kasper S, et al. Subsyndromale Angstst\u00f6rungen: Definition, Messparameter, Epidemiologie. Neurol Neurochir Psychiatr, 10(Pre-Publishing Online): 1\u20136, 2009","journal-title":"Neurol Neurochir Psychiatr"},{"key":"845_CR7","doi-asserted-by":"crossref","first-page":"879","DOI":"10.1097\/NMD.0b013e3181c29992","volume":"197","author":"AE Lawrence","year":"2009","unstructured":"Lawrence AE, Brown TA. Differentiating generalized anxiety disorder from anxiety disorder not otherwise specified. J Nerv Ment Dis, 197: 879\u2013886, 2009","journal-title":"J Nerv Ment Dis"},{"key":"845_CR8","doi-asserted-by":"crossref","first-page":"1073","DOI":"10.1017\/S0033291705004538","volume":"35","author":"RC Kessler","year":"2005","unstructured":"Kessler RC, Brandenburg N, Lane M, et al. Rethinking the duration requirement for generalized anxiety disorder: evidence from the National Comorbidity Survey Replication. Psychol Med, 35: 1073\u20131082, 2005","journal-title":"Psychol Med"},{"key":"845_CR9","doi-asserted-by":"crossref","first-page":"662","DOI":"10.1016\/j.janxdis.2006.10.004","volume":"21","author":"AM Ruscio","year":"2007","unstructured":"Ruscio AM, Chiu WT, Roy-Byrne P, et al. Broadening the definition of generalized anxiety disorder: effects on prevalence and associations with other disorders in the National Comorbidity Survey Replication. J Anxiety Disord, 21: 662\u2013676, 2007","journal-title":"J Anxiety Disord"},{"key":"845_CR10","doi-asserted-by":"crossref","first-page":"288","DOI":"10.1192\/bjp.174.4.288","volume":"174","author":"HA Pincus","year":"1999","unstructured":"Pincus HA, Davis WW, McQueen LE. 'Subthreshold' mental disorders. A review and synthesis of studies on minor depression and other 'brand names'. Br J Psychiatry, 174: 288\u2013296, 1999","journal-title":"Br J Psychiatry"},{"key":"845_CR11","doi-asserted-by":"crossref","first-page":"613","DOI":"10.1017\/S0033291703001466","volume":"34","author":"PM Lewinsohn","year":"2004","unstructured":"Lewinsohn PM, Shankman SA, Gau JM, et al. The prevalence and co-morbidity of subthreshold psychiatric conditions. Psychol Med, 34: 613\u2013622, 2004","journal-title":"Psychol Med"},{"key":"845_CR12","doi-asserted-by":"crossref","first-page":"544","DOI":"10.1192\/bjp.176.6.544","volume":"176","author":"KA Yonkers","year":"2000","unstructured":"Yonkers KA, Dyck IR, Warshaw M, et al. Factors predicting the clinical course of generalised anxiety disorder. Br J Psychiatry, 176: 544\u20135449, 2000","journal-title":"Br J Psychiatry"},{"key":"845_CR13","doi-asserted-by":"crossref","first-page":"319","DOI":"10.1097\/00004850-200015060-00002","volume":"15","author":"HU Wittchen","year":"2000","unstructured":"Wittchen HU, Carter RM, Pfister H, et al. Disabilities and quality of life in pure and comorbid generalized anxiety disorder and major depression in a national survey. Int Clin Psychopharmacol, 15: 319\u2013328, 2000","journal-title":"Int Clin Psychopharmacol"},{"key":"845_CR14","doi-asserted-by":"crossref","first-page":"867","DOI":"10.1037\/a0015813","volume":"77","author":"T Aune","year":"2009","unstructured":"Aune T, Stiles TC. Universal-based prevention of syndromal and subsyndromal social anxiety: A randomized controlled study. J Consult Clin Psychol, 77: 867\u2013879, 2009","journal-title":"J Consult Clin Psychol"},{"key":"845_CR15","doi-asserted-by":"crossref","first-page":"481","DOI":"10.1016\/S0005-7967(02)00130-4","volume":"41","author":"GJ Diefenbach","year":"2003","unstructured":"Diefenbach GJ, Hopko DR, Feigon S, et al. 'Minor GAD': characteristics of subsyndromal GAD in older adults. Behav Res Ther, 41: 481\u2013487, 2003","journal-title":"Behav Res Ther"},{"key":"845_CR16","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1192\/S0007125000293525","volume":"34","author":"K Rickels","year":"1998","unstructured":"Rickels K, Schweizer E. The spectrum of generalised anxiety in clinical practice: the role of short-term, intermittent treatment. Br J Psychiatry Suppl, 34: 49\u201354, 1998","journal-title":"Br J Psychiatry Suppl"},{"issue":"Suppl 6","key":"845_CR17","doi-asserted-by":"crossref","first-page":"S399","DOI":"10.1016\/S0924-977X(99)00051-6","volume":"9","author":"MH Lader","year":"1999","unstructured":"Lader MH. Limitations on the use of benzodiazepines in anxiety and insomnia: are they justified? Eur Neuropsychopharmacol, 9(Suppl 6): S399\u2013S405, 1999","journal-title":"Eur Neuropsychopharmacol"},{"key":"845_CR18","first-page":"2121","volume":"61","author":"LP Longo","year":"2000","unstructured":"Longo LP, Johnson B. Addiction: Part I. Benzodiazepines \u2013 side effects, abuse risk and alternatives. Am Fam Physician, 61: 2121\u20132128, 2000","journal-title":"Am Fam Physician"},{"key":"845_CR19","doi-asserted-by":"crossref","first-page":"482","DOI":"10.1111\/j.1368-5031.2006.00865.x","volume":"60","author":"HG Westenberg","year":"2006","unstructured":"Westenberg HG, Sandner C. Tolerability and safety of fluvoxamine and other antidepressants. Int J Clin Pract, 60: 482\u2013491, 2006","journal-title":"Int J Clin Pract"},{"key":"845_CR20","unstructured":"European Directorate for the Quality of Medicines an Healthcare. Lavender oil (Lavandulae aetheroleum). In: European, 5th edn. Strasbourg, France. European Directorate for Quality of Medicines and Healthcare (EDQM), pp. 1894\u20131895, 2005"},{"key":"845_CR21","doi-asserted-by":"crossref","first-page":"301","DOI":"10.1002\/ptr.1103","volume":"16","author":"HM Cavanagh","year":"2002","unstructured":"Cavanagh HM, Wilkinson JM. Biological activities of lavender essential oil. Phytother Res, 16: 301\u2013308, 2002","journal-title":"Phytother Res"},{"key":"845_CR22","doi-asserted-by":"crossref","first-page":"461","DOI":"10.1007\/BF00973103","volume":"20","author":"E Elizabetsky","year":"1995","unstructured":"Elizabetsky E, Marschner J, Souza DO. Effects of linalool on glutamatergic system in the rat cerebral cortex. Neurochem Res, 20: 461\u2013465, 1995","journal-title":"Neurochem Res"},{"key":"845_CR23","doi-asserted-by":"crossref","first-page":"277","DOI":"10.1097\/YIC.0b013e32833b3242","volume":"25","author":"S Kasper","year":"2010","unstructured":"Kasper S, Gastpar M, M\u00fcller WE, et al. Silexan, an orally administered Lavandula oil preparation, is effective in the treatment of 'subsyndromal' anxiety disorder: a randomized, double-blind, placebo controlled trial. Int Clin Psychopharmacol, 25: 277\u2013287, 2010","journal-title":"Int Clin Psychopharmacol"},{"key":"845_CR24","doi-asserted-by":"crossref","first-page":"94","DOI":"10.1016\/j.phymed.2009.10.006","volume":"17","author":"H Woelk","year":"2010","unstructured":"Woelk H, Schl\u00e4fke S. A multi-center, double-blind, randomised study of the Lavender oil preparation Silexan in comparison to Lorazepam for generalized anxiety disorder. Phytomedicine, 17: 94\u201399, 2010","journal-title":"Phytomedicine"},{"key":"845_CR25","unstructured":"Kasper S, Anghelescu I, Dienel A. Efficacy of Silexan (WS\u00ae 1265) in Patients with Restlessness and Sleep Disturbance. In: Annual Congress of the German Society for Psychiatry and Psychotherapy (DGPPN). Berlin, Germany; 2010"},{"key":"845_CR26","unstructured":"Uehleke B, Schaper S, Dienel A, et al. Phase II trial on the effects of Silexan in patients with neurasthenia, posttraumatic stress disorder or somatization disorder. Submitted for publication"},{"key":"845_CR27","doi-asserted-by":"crossref","first-page":"46","DOI":"10.1111\/j.2042-7166.2007.tb05918.x","volume":"12","author":"R Stange","year":"2007","unstructured":"Stange R, Schaper S, Uehleke B, et al. Phase II study on the effects of lavender oil (Silexan) in patients with neurasthenia, post-traumatic stress disorders or somatisation disorder (Abstract). Focus Alter Complementary Therapies, 12: 46, 2007","journal-title":"Focus Alter Complementary Therapies"},{"key":"845_CR28","doi-asserted-by":"crossref","first-page":"371","DOI":"10.1016\/S0033-3182(71)71479-0","volume":"12","author":"WW Zung","year":"1971","unstructured":"Zung WW. A rating instrument for anxiety disorders. Psychosomatics, 12: 371\u2013379, 1971","journal-title":"Psychosomatics"},{"key":"845_CR29","doi-asserted-by":"crossref","first-page":"406","DOI":"10.1037\/0022-006X.44.3.406","volume":"44","author":"PC Kendall","year":"1976","unstructured":"Kendall PC, Finch AJ Jr, Auerbach SM, et al. The State-Trait Anxiety Inventory: a systematic evaluation. J Consult Clin Psychol, 44: 406\u2013412, 1976","journal-title":"J Consult Clin Psychol"},{"key":"845_CR30","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1016\/0165-1781(89)90047-4","volume":"28","author":"DJ Buysse","year":"1989","unstructured":"Buysse DJ, Reynolds CF 3rd, Monk TH, et al. The Pittsburgh Sleep Quality Index: a new instrument for psychiatric practice and research. Psychiatry Res, 28: 193\u2013213, 1989","journal-title":"Psychiatry Res"},{"key":"845_CR31","doi-asserted-by":"crossref","first-page":"473","DOI":"10.1097\/00005650-199206000-00002","volume":"30","author":"JE Ware Jr","year":"1992","unstructured":"Ware JE Jr, Sherbourne CD. The MOS 36-item short-form health survey (SF-36). I. Conceptual framework and item selection. Med Care, 30: 473\u2013483, 1992","journal-title":"Med Care"},{"key":"845_CR32","unstructured":"National Institute of Mental Health. 12 \u2013 CGI. Clinical Global Impressions. In: Guy W, (ed) EDCEU assessment in psychopharmacology. U.S. National Institute of Mental Health, Psychopharmacology Research Branch, Rockville, MD, pp. 217\u2013222, 1970"},{"key":"845_CR33","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1007\/s001150050737","volume":"72","author":"H Helmchen","year":"2001","unstructured":"Helmchen H. Unterschwellige psychische St\u00f6rungen. Nervenarzt, 72: 181\u2013189, 2001","journal-title":"Nervenarzt"},{"key":"845_CR34","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/S0010-440X(00)80001-2","volume":"41","author":"H Helmchen","year":"2000","unstructured":"Helmchen H, Linden M. Subthreshold disorders in psychiatry: clinical reality, methodological artifact, and the double-threshold problem. Compr Psychiatry, 41: 1\u20137, 2000","journal-title":"Compr Psychiatry"}],"container-title":["Wiener Medizinische Wochenschrift"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s10354-010-0845-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s10354-010-0845-7\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s10354-010-0845-7","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,5,29]],"date-time":"2019-05-29T16:03:54Z","timestamp":1559145834000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s10354-010-0845-7"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2010,12]]},"references-count":34,"journal-issue":{"issue":"21-22","published-print":{"date-parts":[[2010,12]]}},"alternative-id":["845"],"URL":"https:\/\/doi.org\/10.1007\/s10354-010-0845-7","relation":{},"ISSN":["0043-5341","1563-258X"],"issn-type":[{"value":"0043-5341","type":"print"},{"value":"1563-258X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2010,12]]}}}